BSEResult2d ago · 27 Oct 2026, 07:22 pm
Unaudited Standalone and Consolidated Financial Results for the second quarter and half year ended on September 30, 2026.
Concord Biotech Ltd · 543960
✦ AI SummaryResults
Concord Biotech Ltd has announced unaudited standalone and consolidated financial results for the second quarter and half year ended September 30, 2026, along with the Limited Review Reports issued by M/s. BSR & Co. LLP, the Statutory Auditors. The company has also fixed November 4, 2026, as the record date for the issue of bonus equity shares.
Analysis Scores
Earnings Impact5/10
Growth Catalyst3/10
Governance Concern2/10
Regulatory Risk1/10
Balance Sheet Risk4/10
Liquidity Impact6/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Concord Biotech Ltd - 543960 - Unaudited Standalone And Consolidated Financial Results For The Second Quarter And Half Year Ended On September 30, 2026.